Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Elena S. Koltun, Mallika Singh et al.|Nature|2024Cited by 319
COVID-19 in patients with lung cancerJie Luo, Matthew D. Hellmann, Juliana Eng et al.|Annals of Oncology|2020Cited by 269
Abstract LB002: Mechanisms of acquired resistance to KRAS G12C inhibition in cancerMark M. Awad, Andrew J. Aguirre, Shengwu Liu et al.|Cancer Research|2021Cited by 12
Mechanisms of resistance to active state selective tri-complex RAS inhibitorsBen Sang, Piro Lito, Ling Feng Ye et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 10
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMallika Singh, David Wildes, Matthew Holderfield et al.|Research Square|2023Cited by 5